Search Result "HCC."
Immunotherapy of HCC
Journal: Reviews on Recent Clinical Trials
Volume: 3 Issue: 1 Year: 2008 Page: 31-39
Author(s): Tim F. Greten, Michael P. Manns, Firouzeh Korangy
CDK9: Therapeutic Perspective in HCC Therapy
Journal: Current Cancer Drug Targets
Volume: 20 Issue: 5 Year: 2020 Page: 318-324
Author(s): JÄdrzej Borowczak,Krzysztof Szczerbowski,Ewa Stec,Dariusz Grzanka,Åukasz Szylberg
Potential Therapeutic Strategies to Combat HCC
Journal: Current Molecular Pharmacology
Volume: 15 Issue: 7 Year: 2022 Page: 929-942
Author(s): Azam Ali Sher
Role of Angiogenesis in HCC Development and Therapy
Ebook: Molecular Aspects of Hepatocellular Carcinoma
Volume: 1 Year: 2012
Author(s): Lionel W. Hebbard
Doi: 10.2174/978160805072711201010149
Angiogenesis in Hepatocellular Carcinoma (HCC) and its Potential Applications in the Development of Anti-HCC Drugs
Ebook: Anti-Angiogenesis Drug Discovery and Development
Volume: 3 Year: 2016
Author(s): Guang-Chun Sun,Dai-Wei Zhao,Xu Yang,Lichun Sun
Doi: 10.2174/9781681081557116030006
Rationale for New Drugs Targeting the Tissue Microenvironment in Patients with HCC
Journal: Current Pharmaceutical Design
Volume: 13 Issue: 3 Year: 2007 Page: 3288-3291
Author(s): S. Antonaci, G. Giannelli
Establishment and Validation of a Blood Test-based NomogramtoDiagnose Patients with AFP-negative HCC
Journal: Current Cancer Drug Targets
Volume: 24 Issue: 5 Year: 2024 Page: 556-564
Author(s):
From NAFLD to NASH and HCC: Pathogenetic Mechanisms and Therapeutic Insights
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 2 Year: 2013 Page: 5239-5249
Author(s): Samuele De Minicis, Chris Day, Gianluca Svegliati-Baroni
Expression of Plasma hsa-miR122 in HBV-Related Hepatocellular Carcinoma (HCC) in Vietnamese Patients
Journal: MicroRNA
Volume: 7 Issue: 2 Year: 2018 Page: 92-99
Author(s): Nguyen Bao Quoc,Nguyen Doan Nguyen Phuong,Tang Kim Ngan,Nguyen Thi Minh Linh,Pham Hung Cuong,Nguyen Ngoc Bao Chau
Potential Nanoformulation Approaches for Delivery of HCC Therapeutic Agents
Ebook: Nanotherapeutics for the Treatment of Hepatocellular Carcinoma
Volume: 1 Year: 2022
Author(s):
Doi: 10.2174/9789815039740122010012